Ling Zhou

3.4k citations

59 papers · 2.3k indexed · 2 hit papers · h-index 19

Impact in

Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Neurology top 2%
- Long-Term Effects of COVID-19

Papers in

Biological Psychiatry 2
Pulmonary and Respiratory Medicine 18
- Pulmonary Hypertension Research and Treatments 9

Co-authors: Huiguo Liu Shuang Wei Wei Liu Yan Deng Kui Liu Ming YangLei WangJing Liu
Journals: Diabetes Technology & Therapeutics (2 papers)Journal of the American College of Cardiology (2 papers)Annals of Human Genetics (1 paper)International Journal of Cardiology (1 paper)Journal of Hypertension (1 paper)
Partner nations: China United States United Kingdom

In The Last Decade

Ling Zhou

56 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease 2020 · 759 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Chinese Medical Journal
2020 Chinese Medical Journal

Peers

Countries citing papers authored by Ling Zhou

Since Specialization

Citations

This map shows the geographic impact of Ling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhou more than expected).

Fields of papers citing papers by Ling Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhou. The network helps show where Ling Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Ling Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling Zhou Line = papers co-authored together Ling Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Use of the PaO2/FiO2 ratio in acute pulmonary embolism: a simple and reliable parameter to predict the risk stratification Journal of Thoracic Disease ·Yanan Li, Joel Achenbach, Ling Zhou, Jian Guan, Antônio Mariano Bezerra Pereira, 政信和田, Yun Feng, Dong Liu, Yongjie Ding, Guochao Shi	2025	0
2	Multidisciplinary management strategies for atrial fibrillation Current Problems in Cardiology ·كريم الشيخ بلال, Ling Zhou, Yahui Li, Savannah Elaine Baggett	2024	3
3	A High Immune-Related Index with the Suppression of cGAS-STING Pathway is a Key Determinant to Herceptin Resistance in HER2+ Breast Cancer International Journal of Biological Sciences ·Javier Chaves-Cordero, Qingshan Chen, Г. Н. Манаенко, Yan Wang, Ling Zhou, Kaiming Zhang, P J deBarro, Zhiling Li, Yuhong Chen, Hailiang Zhang, Gong‐Kan Feng, Xiao‐Feng Zhu, Rong Deng, Jun Tang	2024	6
4	Adverse events associated with tezepelumab: a safety analysis of clinical trials and a pharmacovigilance system Expert Opinion on Drug Safety ·Zhenyu Mao, Yuchen Huang, Xiaoyan Zhu, YangJinHee, Lingling Wang, Fengqin Zhang, Wei Liu, 손지훈, Wenhui Liao, Ling Zhou	2024	0
5	Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice Experimental Hematology and Oncology ·Ling Zhou, Yunlong Lu, Wei Liu, 浩司衛藤, Lingling Wang, YangJinHee, Shaohua Huang, Huiguo Liu, Wukun Liu, Shuang Wei	2024	16
6	The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study Frontiers in Pharmacology ·Ling Zhou, Yan Deng, Kui Liu, Huiguo Liu, Amanda J. Reid	2024	1
7	Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinoma Cancer Cell International ·YangJinHee, Zhenyu Mao, Miao Luo, Ling Zhou, Lingling Wang, Huiguo Liu, Wei Liu, Shuang Wei	2023	27
8	Analysis of postoperative pulmonary complications after gastrectomy for gastric cancer: development and validation of a nomogram Frontiers in Surgery ·Ling Zhou, Giuseppe Betino, M. Laake, Cunming Liu	2023	5
9	IL-27 attenuates airway inflammation and epithelial-mesenchymal transition in allergic asthmatic mice possibly via the RhoA/ROCK signalling pathway European Cytokine Network ·Renzo Castagnino Abásolo, Yan Sun, Na Liu, Ziping Zhang, Xiyan Wang, Taaн Аль-Баяти Гази Хусейн, Ling Zhou, Wei Zhang	2022	5
10	Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity Frontiers in Molecular Biosciences ·YangJinHee, Shirley D'Sa, Karint Teresa Velarde Loayza, Lingling Wang, Lu Liu, Yuhao Zhou, Ling Zhou, Huiguo Liu	2022	7
11	Swine Acute Diarrhea Syndrome Coronavirus Nucleocapsid Protein Antagonizes Interferon-β Production via Blocking the Interaction Between TRAF3 and TBK1 Frontiers in Immunology ·A. Bravais, Yuan Sun, Jingya Xu, Xiaoyu Tang, Ling Zhou, Abraham Agyemang, Tian Lan, Jingyun Ma	2021	16
12	Pivotal role of the gut microbiota in congenital insensitivity to pain with anhidrosis Psychopharmacology ·Mi Zhang, Ronald M. Schnedier, Nina Nilsen Rydeback, Ningbo Li, Siti Nasfirah, Christienne Javier, Y. Wang, Ting Ye, Ling Zhou, Cunming Liu, Chun Yang, Xianwei Zhang	2021	8
13	Identification of novel biomarker and therapeutic target candidates for acute intracerebral hemorrhage by quantitative plasma proteomics Clinical Proteomics ·Guochun Li, Lina Zhang, Ming Yu, Philip Lo Presti, Ting Tian, Junqin Wang, Fuqiang Wang, Ling Zhou	2017	17
14	Hair follicle stem cell proliferation, Akt and Wnt signaling activation in TPA-induced hair regeneration Histochemistry and Cell Biology ·Weiming Qiu, Mingxing Lei, Ling Zhou, Xiufeng Bai, Yuhan Jin, Helsingin, Tian Yang, Xiaohua Lian	2017	40
15	[Incidence and outcome of anti-tuberculosis drug-induced hepatotoxicity in tuberculosis inpatients]. PubMed ·Dorothy A. Leonard, Ling Zhou, Yongzhong Chen, Hongqiu Pan, Shaowen Tang	2016	2
16	TCT-683 Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study Journal of the American College of Cardiology ·Shaoliang Chen, Wataru Yamakoshi, Gregg W. Stone, Wenda Permana, Ling Zhou	2013	5
17	Single-nucleotide polymorphisms inside microRNA target sites influence the susceptibility to type 2 diabetes Journal of Human Genetics ·Carlile Lowery, Qing Ye, Kang Xu, Jinluo Cheng, Yanqin Gao, George Ville, Juan Du, Hui Shi, Ling Zhou	2013	30
18	Association Between PPAR-γ and RXR-α Gene Polymorphism and Metabolic Syndrome Risk: A Case-Control Study of a Chinese Han Population Archives of Medical Research ·Hui Shi, 中尾宏司, Qian Li, Georg Holtzinger, Yanqin Gao, Jianhua Ma, Jinluo Cheng, Ying Lu, Lidia Sánchez-Morales, Juan Du, Qing Ye, Xu Zhao, Ling Zhou	2012	16
19	Genetic Variants in the ADIPOQ Gene and the Risk of Metabolic Syndrome: A Case‐Control Study of a Chinese Han population Annals of Human Genetics ·Juan Du, Ibrahim Abe Baggili, Qian Li, 中尾宏司, Jinluo Cheng, Jianhua Ma, Yanqin Gao, Ying Lu, Lidia Sánchez-Morales, Hui Shi, Xu Zhao, Qing Ye, Ling Zhou	2012	9
20	Genetic variants in protein kinase C zeta gene and type 2 diabetes risk: a case‐control study of a Chinese Han population Diabetes/Metabolism Research and Reviews ·Lei Qin, Ling Zhou, Xueji Wu, Jinluo Cheng, Jingsong Wang, Widia Wardani, Jihong Hu, Rodríguez Rigual M, Jinyi Zhou	2008	6

About Ling Zhou

Ling Zhou is a scholar working on Biological Psychiatry, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Cancer Research and Immunology, having authored 59 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (9 papers), Cardiovascular Function and Risk Factors (6 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Adipose Tissue and Metabolism (5 papers), Cancer-related molecular mechanisms research (4 papers), Cardiovascular Issues in Pregnancy (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Neurology (608 citations), Cardiology and Cardiovascular Medicine (377 citations), Biological Psychiatry (38 citations) and Pulmonary and Respiratory Medicine (487 citations). Ling Zhou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Huiguo Liu, Shuang Wei, Wei Liu, Yan Deng, Kui Liu, Ming Yang, Lei Wang, Jing Liu, Yi Hu and Shao‐Liang Chen. Their work appears in journals such as Diabetes Technology & Therapeutics, Journal of the American College of Cardiology, Annals of Human Genetics, International Journal of Cardiology and Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact